Investor Relations

Corporate Overview

We are a global medical technology company focused on the development and commercialization of our proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress. Our Hi-VNI® Technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Our Precision Flow systems, which use Hi-VNI® Technology, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. As of March 31, 2020, more than 2.2 million patients have been treated with our Precision Flow systems, and we have a global installed base of over 17,000 capital units.

Latest News

View all news

Latest Presentation

Latest Events

View All Events

Latest Quarterly Reports

View All Financial Reports